Reuters logo
BRIEF-Shanxi Zhendong Pharmaceutical sees FY 2017 H1 net profit to increase by 355 pct to 385 pct
July 13, 2017 / 6:48 AM / 5 months ago

BRIEF-Shanxi Zhendong Pharmaceutical sees FY 2017 H1 net profit to increase by 355 pct to 385 pct

July 13(Reuters) - Shanxi Zhendong Pharmaceutical Co Ltd :

* Says net profit for FY 2017 H1 to increase by 355 percent to 385 percent, or to be 157 million yuan to 167.3 million yuan, compared to net profit of FY 2016 H1 (34.5 million yuan)

Source text in Chinese: goo.gl/C4WUvz

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below